Recent Advances in the Molecular Mechanisms of Neurodegenerative Diseases: Current Progress and Future Directions for Disease-Modifying Therapies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Aging".
Deadline for manuscript submissions: 10 November 2025 | Viewed by 89
Special Issue Editors
Interests: pharmacology; new drug discovery; myokines; physical exercise; neurodegenerative diseases; dementia
Interests: pharmacology; natural products; gut microbiota; dietary supplements; nutrition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As life expectancy increases due to advances in medical care, humanity faces a new crisis associated with the growing aging population. This results in a corresponding increase in the prevalence of incurable neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington's disease, Multiple sclerosis, and Amyotrophic lateral sclerosis. These diseases typically affect brain activity in the elderly by impairing their cognitive and behavioral functions. Notably, several pathogenic features—including specific neuronal loss, gliosis, oxidative stress, mitochondrial dysfunction, neuroinflammation, and gut dysfunction—tend to overlap in common neurodegenerative diseases. Despite advances in our understanding, the development of disease-modifying treatments that target the underlying molecular mechanisms of disease pathogenesis remains challenging; only a few symptomatic-modifying therapies are currently available for PD, but not disease-modifying therapies. Therefore, this Special Issue aims to explore the potential disease-modifying therapies related to the advancement of research on the neuropathogenesis of neurodegenerative diseases, with the goal of achieving significant breakthroughs in disease modeling and drug development. The original research articles and reviews focused on investigating the natural drug, neuroprotective signaling mechanisms, microglial-mediated neuroinflammation, and neuronal cell death, as well as the relationship between the gut–brain axis. We also invite you to submit research and review articles that focus on the relationship between physical exercise and neurodegenerative diseases. These articles should explore how different types of physical exercise regulate brain function and contribute to the prevention of neurodegenerative diseases, as well as how non-pharmacological therapeutic strategies can reduce disease progression through exercise interventions.
Dr. Rengasamy Balakrishnan
Dr. Balamuralikrishnan Balasubramanian
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroprotection
- new drug development
- natural products
- blood–brain barrier
- molecular mechanisms
- neuronal signaling
- neuroinflammation
- microglial cells
- neurotoxicity
- neurodegenerative diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
